Compugen Ltd CGEN.OQ, CGEN.O is expected to show a fall in quarterly revenue when it reports results on August 6 for the period ending June 30 2025
The Holon Israel-based company is expected to report a 41.0% decrease in revenue to $3.952 million from $6.7 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
LSEG's mean analyst estimate for Compugen Ltd is for a loss of 6 cents per share.
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Compugen Ltd is $4.00, about 63% above its last closing price of $1.48
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | -0.06 | -0.05 | -0.08 | Missed | -45.5 |
Dec. 31 2025 | 0.05 | 0.07 | -0.07 | Missed | -195.5 |
Sep. 30 2024 | 0.21 | 0.11 | 0.01 | Missed | -90.5 |
Jun. 30 2024 | -0.07 | -0.07 | -0.02 | Beat | 71 |
Mar. 31 2024 | -0.02 | -0.02 | -0.08 | Missed | -263.6 |
Dec. 31 2023 | 0.29 | 0.23 | 0.11 | Missed | -51.1 |
Sep. 30 2023 | -0.12 | -0.09 | -0.11 | Missed | -19.1 |
Jun. 30 2023 | -0.13 | -0.13 | -0.11 | Beat | 12.5 |
This summary was machine generated August 4 at 13:38 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)